Literature DB >> 15513016

Canaliculitis: the incidence of long-term epiphora following canaliculotomy.

Seema Anand1, Kay Hollingworth, Vinod Kumar, Soupramanien Sandramouli.   

Abstract

PURPOSE: To review the long-term outcome following surgical treatment for canaliculitis.
METHODS: All cases of canaliculitis treated surgically from January 1995 to December 2001 were identified from theatre records. Case notes were reviewed retrospectively looking specifically for delay in diagnosis (defined as two or more visits prior to diagnosis), culture results and outcome following surgical treatment. Telephonic questionnaires were used to assess the incidence of post-treatment epiphora. Symptomatic patients were offered clinic appointments for further assessment and management.
RESULTS: Fifteen eyes of 15 patients were identified, 13 were females and 2 males. Mean age was 69.6 years (range 45-87 years). One patient had both upper and lower canaliculitis. The remaining 14 (93.3%) had lower canaliculitis. Diagnosis was delayed in 7 of the 15 patients (46.6%). Culture results were positive in 66.6% with Staphylocococcus spp. being the most common isolate (26.6%). Actinomyces was isolated in only 2 of the 15 cases (13.3%). Conservative treatment had been tried in 5 cases (33.3%). All patients had resolution of symptoms following canaliculotomy. Epiphora was identified in four of the treated eyes on telephonic questionnaires. Of these, three eyes had preexisting lacrimal pathology. Average follow-up was 26 months (range 6-83 months).
CONCLUSION: Canaliculotomy is safe and efficacious in the treatment of lacrimal canaliculitis with no demonstrable risk of posttreatment epiphora.

Entities:  

Mesh:

Year:  2004        PMID: 15513016     DOI: 10.1076/orbi.23.1.19.28985

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  20 in total

1.  Actinomyces canaliculitis and its surgical treatment.

Authors:  Dilek Yuksel; Dicle Hazirolan; Gulten Sungur; Sunay Duman
Journal:  Int Ophthalmol       Date:  2012-02-15       Impact factor: 2.031

2.  67-year-old male with right eye discharge.

Authors:  Anya A Trumler
Journal:  Oman J Ophthalmol       Date:  2011-01

3.  Clinical characteristics, treatment patterns, and outcomes of primary canaliculitis among patients in Beijing, China.

Authors:  Qin Zhang; Beibei Xu; Xiao-Xin Li; Ming-Wu Li
Journal:  Biomed Res Int       Date:  2015-02-17       Impact factor: 3.411

4.  A Pathological Analysis of Canaliculitis Concretions: More Than Just Actinomyces.

Authors:  Balaji Perumal; John Andrew Carlson; Dale Robert Meyer
Journal:  Scientifica (Cairo)       Date:  2016-06-14

5.  Canaliculitis Awareness.

Authors:  Melike Balıkoğlu Yılmaz; Emine Şen; Ebru Evren; Ufuk Elgin; Pelin Yılmazbaş
Journal:  Turk J Ophthalmol       Date:  2016-01-05

6.  Clinical features and bacteriology of lacrimal canaliculitis in patients presenting to a tertiary eye care center in the Middle East.

Authors:  Mohammed Gogandy; Osama Al-Sheikh; Imtiaz Chaudhry
Journal:  Saudi J Ophthalmol       Date:  2014-01

7.  Lacrimal canaliculitis.

Authors:  Jill Zaveri; Adam J Cohen
Journal:  Saudi J Ophthalmol       Date:  2013-11-13

8.  Novel Therapy for Primary Canaliculitis: A Pilot Study of Intracanalicular Ophthalmic Corticosteroid/Antibiotic Combination Ointment Infiltration.

Authors:  Jianjiang Xu; Zuguo Liu; Alireza Mashaghi; Xinghuai Sun; Yi Lu; Yimin Li; Dan Wu; Yujing Yang; Anji Wei; Yujin Zhao; Chun Lu; Jiaxu Hong
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

9.  A treatment method for chronic suppurative lacrimal canaliculitis using chalazion forceps.

Authors:  Xiuming Jin; Fangli Fan; Fan Zhang; Yingying Zhao; Renjian Hu
Journal:  Indian J Ophthalmol       Date:  2016-08       Impact factor: 1.848

10.  Primary canaliculitis: The incidence, clinical features, outcome and long-term epiphora after snip-punctoplasty and curettage.

Authors:  Usha R Kim; Bhagwati Wadwekar; Lalitha Prajna
Journal:  Saudi J Ophthalmol       Date:  2015-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.